NewLimit
company on 7 shows · 11 statements across 4 episodes · said 39 times in 13 episodes since 2021
All-In 11 
No Priors 9 
David Senra 9 
TBPN 5 
WTF is with Nikhil Kamath 2 
Sourcery 2 
the a16z Podcast 1
Mentions by year, every show
tap a year for its mentions
All-In 11David Senra 9No Priors 9TBPN 5Sourcery 2WTF is with Nikhil Kamath 2the a16z Podcast 1
2026 31 mentions in 7 episodes 4 per episode
- Coinbase’s Everything Exchange: Agentic Finance, Stablecoins & Tokenization with CEO Brian Armstrong
- Brian Armstrong: When Washington Tried to Kill Coinbase
- Coinbase CEO's Top 3 Crypto Trends for 2026 + More from Davos!
- Brian Armstrong: Bitcoin, Banks & The New Rules Of Money | Nikhil Kamath | People by WTF · Nikhil Kamath
- Andrew Feldman on Building a Chip 58x Larger Than Nvidia's · Sourcery with Molly O'Shea
- Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI's Atari Stage
- Palantir's AIPCon 10, Ramp Hits $44B, 60 Minutes Eyes Rogan | Diet TBPN
- every mention in 2026, scene by scene →
2025 5 mentions in 4 episodes 1 per episode
2023 2 mentions in 1 episode
2021 1 mention in 1 episode
every mention on every show, scene by scene, with the transcript →
11 statements about NewLimit, every show
Armstrong claims New Limit built the leading frontier model for epigenetic reprogramming
“We've built the leading frontier model for epigenetic reprogramming.”
Armstrong: New Limit will launch its first Phase 1 clinical trial next year
“And then the first phase one clinical trial will be launching next year.”
Armstrong: New Limit's initial clinical trial targets alcoholic liver disease
“With our liver program, the initial phase one clinical trial will be in people with alcohol liver disease or alcoholic liver ALD.”
Armstrong estimates an effective ALD drug might be worth $20 billion
“I think we estimated that yeah, like just that if that were drug alone works in ALD, it might be worth twenty billion dollars or something.”
Bryan Johnson: New Limit computationally solved cellular reprogramming factor discovery
“They've done, I mean, they've made remarkable progress. They figured out how to computationally Solve the discovery process. And so they they're much faster than they initially thought.”
Bryan Johnson: GLP-1s and plasmid therapies will drive major longevity shifts
“In the future, like, I think we'll look back and we'll see GLP ones as the first big drop. Like what I can just inject myself and like it solves hunger and totally. Yeah. And then the second will probably be something like new limit or one of these Fox, one of…”
Armstrong: NewLimit successfully reprogrammed human cells to restore function
“We've demonstrated successfully programming human cells for the first time to restore function.”
Armstrong: NewLimit's first drug candidate will probably enter clinical trials next year
“And the first drug can that's going to go into clinical trials probably next year.”
Armstrong committed $100M of personal capital to launch NewLimit
“Committed a hundred million of my own money to it to hope, to help it get off the ground, and it subsequently raised more money from others as well”
Armstrong: New Limit demonstrated cell reprogramming to restore youthful function
“Within the first two or three years, they were able to successfully demonstrate reprogramming of human cells to sort of function they had when they were younger.”